China Universal Asset Management Company’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $725K | Buy |
33,614
+159
| +0.5% | +$3.43K | 0.07% | 211 |
|
|
2025
Q1 | $556K | Sell |
33,455
-1,826
| -5% | -$30.3K | 0.05% | 240 |
|
|
2024
Q4 | $647K | Buy |
35,281
+3,378
| +11% | +$62K | 0.06% | 216 |
|
|
2024
Q3 | $491K | Buy |
31,903
+12,493
| +64% | +$192K | 0.05% | 220 |
|
|
2024
Q2 | $315K | Sell |
19,410
-12,244
| -39% | -$199K | 0.04% | 185 |
|
|
2024
Q1 | $585K | Buy |
31,654
+12,669
| +67% | +$234K | 0.07% | 170 |
|
|
2023
Q4 | $594K | Buy |
18,985
+14,783
| +352% | +$463K | 0.12% | 135 |
|
|
2023
Q3 | $87.6K | Buy |
4,202
+2,070
| +97% | +$43.1K | 0.03% | 201 |
|
|
2023
Q2 | $51.1K | Sell |
2,132
-66
| -3% | -$1.58K | 0.02% | 189 |
|
|
2023
Q1 | $41.4K | Buy |
2,198
+553
| +34% | +$10.4K | 0.01% | 164 |
|
|
2022
Q4 | $26.2K | Buy |
1,645
+130
| +9% | +$2.07K | 0.01% | 162 |
|
|
2022
Q3 | $25K | Buy |
+1,515
| New | +$25K | 0.01% | 143 |
|